EW vs PRLB · P/E 47, rev $1.39B vs P/E 75, $1.89B cap
Edwards Lifesciences Corp (EW) versus Proto Labs Inc (PRLB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Proto Labs Inc (PRLB) is a metal fabrication company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
PRLB does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRLB currently screens at market cap $1.89B and trailing P/E 75.1.
Not investment advice. Open the EW and PRLB stock pages for the full models.
Not investment advice.